MPR Weekly Dose Podcast #156

Updates to COVID-19 vaccines; FDA panel votes on potential treatment for agitation with Alzheimer dementia; DEA deschedules drug; Migraine treatment indication expanded; A new device is cleared to aid in restless legs syndrome.